Background and Purpose—We report a preclinical study of a new endoluminal device for
aneurysm occlusion to test the hypothesis that the device, even without use of intrasaccular …

Animal models are necessary to develop and test innovations in aneurysm therapy before
clinical introduction. This review aims at identifying the most likely candidates for …

Preclinical studies are important in helping practitioners and device developers improve
techniques and tools for endovascular treatment of intracranial aneurysms. Thus an …

A reverse engineering methodology is presented for identifying environmentally conscious
design guidelines for use in the conceptual stages of product design. Environmentally …

Background Semiquantitative scales correlate histopathologic findings in the walls of human
aneurysms with rupture status. Objective To apply a semiquantitative scale to the rabbit …

Intracranial aneurysm (IA) animal models are paramount to study IA pathophysiology and to
test new endovascular treatments. A number of in vivo imaging modalities are available to …

Background Herein, we report an in vivo study of a biodegradable flow diverter (BDFD) for
aneurysm occlusion. Conceptually, BDFD s induce a temporal flow‐diverting effect and …

BACKGROUND AND PURPOSE: Animal models with appropriate volume are crucial for
preclinical assessment of aneurysm therapies. Our purpose was to control the aneurysm …

Purpose Preclinical testing of neurovascular devices is crucial for successful device design
and is commonly performed using in vivo organisms such as the rabbit elastase-induced …

Introduction Flow diverters (FDs) are increasingly used in the treatment of wide-necked
aneurysms. Objective To examine the hypothesis that intentional FD compaction might …